Expedited IRB Review: Who Qualifies and How to Apply
Navigating the Institutional Review Board (IRB) review process is a critical step in launching any human subjects research study. While some studies require full board review, many researchers may be eligible for expedited IRB review—a faster approval pathway that can significantly reduce your time to study initiation. Understanding who qualifies for expedited review and how to properly apply can save valuable time and resources while maintaining the highest ethical standards.
What Is Expedited IRB Review?
Expedited IRB review is a streamlined evaluation process for research that presents no more than minimal risk to participants. Rather than waiting for a convened IRB meeting where the full board discusses your protocol, expedited review allows one or more experienced IRB reviewers to evaluate your study independently. This process typically results in faster approval decisions—often within days rather than weeks.
The expedited review category was established by federal regulations (45 CFR 46.110 and 21 CFR 56.110) to allow lower-risk research to proceed more quickly while still maintaining appropriate ethical oversight and participant protections.
Who Qualifies for Expedited IRB Review?
The Department of Health and Human Services (HHS) has identified specific categories of research that qualify for expedited review. Understanding these categories is essential for determining whether your study is eligible.
Research Categories Eligible for Expedited Review
1. Clinical Studies of Drugs and Medical Devices
Your research may qualify if it involves: - Drugs for which an investigational new drug (IND) application is not required - Medical devices for which an investigational device exemption (IDE) is not required, or the device is cleared/approved for marketing and being used according to its cleared/approved labeling
2. Collection of Biological Specimens by Non-Invasive Means
This includes: - Hair and nail clippings collected in a non-disfiguring manner - Deciduous teeth at time of exfoliation or extraction - Excreta and external secretions (including sweat) - Uncannulated saliva collection - Placenta removal at delivery - Amniotic fluid at the time of rupture of membranes - Dental plaque and calculus from procedures that don't deviate from standard prophylactic techniques
3. Collection of Data Through Non-Invasive Procedures
Examples include: - Physical sensors applied to the body surface - Weighing or testing sensory acuity - Moderate exercise by healthy volunteers - Magnetic resonance imaging (MRI) - Electrocardiography, electroencephalography, and other diagnostic procedures
4. Research on Existing Data, Documents, or Specimens
Your study qualifies if it involves: - Collection or study of existing data, documents, records, or pathological/diagnostic specimens - The information is recorded in a manner that subjects cannot be identified directly or through identifiers
5. Voice, Video, or Image Recording
Research involving recording for research purposes may qualify when: - The information won't place subjects at risk of criminal or civil liability - The research won't damage subjects' financial standing, employability, insurability, or reputation
Research on Vulnerable Populations
Important considerations apply when your research involves vulnerable populations:
- Children: Some categories of pediatric research may qualify for expedited review, but additional scrutiny typically applies
- Pregnant women: Research involving pregnant women may be expedited only under specific conditions
- Prisoners: Research involving prisoners generally requires full board review with specific representation requirements
- Cognitively impaired individuals: May qualify for expedited review depending on risk level and procedures involved
Key Requirements: The Minimal Risk Standard
The cornerstone of expedited review eligibility is the concept of minimal risk. Federal regulations define minimal risk as research where "the probability and magnitude of harm or discomfort anticipated in the research are not greater in and of themselves than those ordinarily encountered in daily life or during the performance of routine physical or psychological examinations or tests."
Your research must meet this minimal risk threshold to qualify for expedited review. Consider these questions:
- Could the research procedures cause more than temporary discomfort?
- Is there any reasonable possibility of serious harm?
- Does the research involve deception that could cause psychological distress?
- Are there potential privacy breaches that could harm participants?
If you answer "yes" to any of these questions, your study likely requires full board review.
Minor Changes to Approved Research
Expedited review also applies to minor modifications of previously approved research during the period for which approval is authorized. These minor changes might include:
- Small adjustments to recruitment materials
- Administrative changes to the protocol that don't affect risk or benefits
- Minor revisions to consent language for clarity
- Addition of research personnel
However, changes that increase risk, substantially alter the study design, or affect participant safety require full board review.
How to Apply for Expedited IRB Review
Step 1: Confirm Your Eligibility
Before submitting your application, carefully review the expedited categories and confirm that your research: - Fits within one or more expedited categories - Presents no more than minimal risk to participants - Doesn't involve vulnerable populations requiring additional protections (or meets specific criteria for those populations)
Step 2: Prepare Your IRB Application
Your expedited review application should include:
Protocol Documentation - Detailed research protocol describing objectives, methodology, and procedures - Clear identification of the expedited category/categories that apply - Risk-benefit analysis demonstrating minimal risk - Data and safety monitoring plan (if applicable)
Informed Consent Documents - Informed consent form using clear, accessible language - HIPAA authorization (if collecting protected health information) - Assent forms (if involving children)
Supporting Materials - Recruitment materials (advertisements, scripts, emails) - Survey instruments or interview guides - Investigator brochures or device manuals - Letters of support from participating sites - Conflict of interest disclosures
Step 3: Clearly Justify Expedited Review
In your application, explicitly state: - Which expedited category/categories apply to your research - Why your research presents minimal risk - How participant privacy and confidentiality will be protected - Any additional safeguards you've implemented
Don't assume the reviewer will automatically recognize why your study qualifies. Make your case clearly and comprehensively.
Step 4: Submit and Respond Promptly
Once submitted: - Monitor your IRB portal or email for communications - Respond quickly to any requests for clarification or modifications - Be prepared to provide additional information if needed - Understand that the IRB retains authority to refer your study to full board review if concerns arise
Common Mistakes to Avoid
Assuming Qualification: Don't simply select "expedited review" without thoroughly evaluating your eligibility. Misclassification can delay your approval.
Incomplete Applications: Missing documents or vague protocol descriptions will result in requests for additional information, delaying your review.
Underestimating Risk: Be honest about potential risks. Reviewers are experienced at identifying risks you might overlook.
Generic Consent Forms: Tailor your informed consent documents to your specific study and population. Template language should be customized.
Ignoring Site-Specific Requirements: If you're conducting multi-site research, ensure you understand each site's IRB requirements.
Timeline Expectations
While expedited review is faster than full board review, timelines vary:
- Expedited Review: Typically 5-10 business days, though this can vary by IRB
- Full Board Review: Generally 4-6 weeks, depending on meeting schedules
Building realistic timelines into your research planning ensures you're not pressured to rush the IRB process, which could compromise quality.
What If Your Study Doesn't Qualify?
If your research doesn't meet expedited review criteria, don't view it as a setback. Full board review provides: - Diverse perspectives on your research design - Robust evaluation of ethical considerations - Enhanced credibility for your study - Opportunity to address complex ethical issues thoroughly
Working with an experienced IRB that understands your research area can make full board review efficient and constructive.
Maintaining Approval: Post-Approval Responsibilities
Once your expedited review is approved, remember your ongoing responsibilities:
- Submit continuing review applications before approval expiration
- Report unanticipated problems or adverse events promptly
- Request approval for any protocol modifications before implementation
- Maintain accurate records of consent and study procedures
- Close your study properly when research concludes
Streamline Your Expedited Review Process with Elemental IRB
Navigating IRB requirements—even for expedited review—requires expertise and attention to detail. At Elemental IRB, we specialize in efficient, thorough ethical review that keeps your research moving forward while maintaining the highest standards of participant protection.
Our experienced reviewers understand the nuances of expedited review categories and work collaboratively with researchers to facilitate timely approvals. Whether you're conducting clinical trials, academic research, or commercial studies, we provide responsive, knowledgeable support throughout the IRB process.
Ready to submit your expedited review application? Contact Elemental IRB today to learn how our streamlined processes and expert guidance can help you achieve faster approval without compromising quality or compliance. Let us handle the complexities of IRB review so you can focus on advancing your important research.